Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

Tuesday July 2, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, discuss HCC highlights from ASCO 2019.

Featured Videos

Lowell L. Hart, MD, FACP, regarding recent data investigating trilaciclib in SCLC

Saad Usmani, MD, FACP, regarding outcomes from the MAIA study presented at ASCO 2019

Sandip Patel, MD, on treating non-squamous NSCLC patients expressing high levels of PD-L1